자료유형 | 학위논문 |
---|---|
서명/저자사항 | LYN Regulates Drug Resistance Mechanisms in Chronic Myelogenous Leukemia (CML). |
개인저자 | Okumu, Denis O. |
단체저자명 | The University of North Carolina at Chapel Hill. Pharmacology. |
발행사항 | [S.l.]: The University of North Carolina at Chapel Hill., 2018. |
발행사항 | Ann Arbor: ProQuest Dissertations & Theses, 2018. |
형태사항 | 135 p. |
기본자료 저록 | Dissertation Abstracts International 79-10B(E). Dissertation Abstract International |
ISBN | 9780438065741 |
학위논문주기 | Thesis (Ph.D.)--The University of North Carolina at Chapel Hill, 2018. |
일반주기 |
Source: Dissertation Abstracts International, Volume: 79-10(E), Section: B.
Advisers: Lee M. Graves |
요약 | Acquired resistance to anti-cancer therapy presents a critical challenge to effective clinical management of chronic myelogenous leukemia (CML). Drug-resistant CML cells devise diverse molecular adaptations to evade therapy. Examples of such ada |
요약 | In the first project, I showed that increased Lyn expression and activity in Myl-R cells up-regulated the expression and stability of BIRC6, a member of the inhibitor of apoptosis proteins (IAP) family known to bind and inactivate active caspase |
요약 | In the second project, I am investigating Lyn's role in regulating creatine uptake by Myl-R cells. Our lab previously showed that total intracellular creatine pool was 5-fold higher in Myl-R than Myl cells. Our unpublished data show that the inc |
요약 | Taken together, these studies enrich our understanding of the diverse therapy-survival mechanisms utilized by CML cells, and provide insights into novel targets for effective cure of CML. |
일반주제명 | Pharmacology. |
언어 | 영어 |
바로가기 |
: 이 자료의 원문은 한국교육학술정보원에서 제공합니다. |